Suchergebnisse
Suchergebnisse:
Charles Brenton Huggins war ein kanadisch-US-amerikanischer Chirurg, Krebsforscher und Nobelpreisträger. Er war Spezialist für Prostatakrebs und entdeckte 1941, dass dessen Entwicklung durch Hormone beeinflusst werden konnte. Dies ermöglichte erste systematische Therapiemöglichkeiten gegen diese Krebsart und war gleichzeitig der erste ...
Charles Brenton Huggins (September 22, 1901 – January 12, 1997) was a Canadian-American surgeon and physiologist known for his work on prostate function, prostate cancer, and breast cancer. Born in Halifax in 1901, Huggins moved to the United States for medical school.
The Nobel Prize in Physiology or Medicine 1966 was divided equally between Peyton Rous "for his discovery of tumour-inducing viruses" and Charles Brenton Huggins "for his discoveries concerning hormonal treatment of prostatic cancer"
Nobel Prize winner Charles B. Huggins, MD was born on September 2, 1901 in Halifax, Nova Scotia where he went to public school and college. His first major research dealt with induced transformation of one cell type into another, transforming fibrous tissue into bone by implanting bladder epithelium in a different host site.
12. Jan. 1997 · Charles Brenton Huggins. The Nobel Prize in Physiology or Medicine 1966. Born: 22 September 1901, Halifax, Nova Scotia, Canada. Died: 12 January 1997, Chicago, IL, USA. Affiliation at the time of the award: University of Chicago, Ben May Laboratory for Cancer Research, Chicago, IL, USA.
Charles B. Huggins was a Canadian-born American surgeon and urologist whose investigations demonstrated the relationship between hormones and certain types of cancer. For his discoveries, Huggins received (with Peyton Rous) the Nobel Prize for Physiology or Medicine in 1966. Huggins was educated at.
Huggins, Charles Brenton, kanadisch-amerikan. Chirurg, *22.9.1901 Halifax (Kanada), †12.1.1997; ab 1936 Professor und seit 1951 Leiter des Ben-May-Laboratoriums für Krebsforschung in Chicago (Ill.); arbeitete hauptsächlich auf dem Gebiet der Tumorchemotherapie; wies 1941 nach, daß der Prostatakrebs durch Applikation weiblicher ...
